Diseases of the Colon & Rectum

, Volume 34, Issue 3, pp 217–222 | Cite as

The value of radioimmunoguided surgery in first and second look laparotomy for colorectal cancer

  • P. M. Dawson
  • S. D. Blair
  • R. H. J. Begent
  • A. M. B. Kelly
  • G. M. Boxer
  • N. A. Theodorou
Original Contributions
  • 21 Downloads

Abstract

Radioimmunoguided surgery (RIGS) using an anti-CEA (A5B7) monoclonal antibody has been assessed in 52 patients (43 primary excisions and nine second look procedures) undergoing surgery for colorectal carcinoma. The antibody localized in 97.8 percent of primary tumours and in 88.8 percent of the principal tumor in second look procedures. Additional information concerning the extent of primary tumor was obtained in 11 of 43 patients (25.5 percent) undergoing excision of primary carcinoma and five of nine patients (55 percent) in the second look series. Incorrect information was obtained about the extent of the primary tumour in six patients (11.3 percent), whereas no incorrect information was obtained during second look procedures. RIGS correctly predicted the subsequent Dukes' staging in 77 percent of first look cases (sensitivity 65 percent, specificity 90 percent), although accurate identification of individual nodes was impossible. The technique influenced the surgical procedure performed in 2 of 43 cases (4.6 percent) in primary surgery and in three of nine patients undergoing second look laparotomy (33 percent). RIGS in primary colorectal carcinoma may provide additional information concerning extent of locally advanced tumors in particular and the principle that the subsequent surgery may be influenced has been established. The technique appears to have a greater role in second look procedures where it may help determine the extent of recurrent tumour. Larger follow-up series are required to define how the additional information provided by this technique may best be exploited.

Key words

Radioimmunoguided surgery Colorectal cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;2:1479–82.Google Scholar
  2. 2.
    Nicholls RJ, York-Mason A, Morson BC, Dixon AK, Kelsey-Fry I. The clinical staging of rectal cancer. Br J Surg 1982;69:404–9.PubMedGoogle Scholar
  3. 3.
    Beynon J, Foy DMA, Roe AM, Temple LN, Mc-Mortensen NJ. Endoluminal ultrasound in the assessment of local invasion of rectal cancer. Br J Surg 1986;73:474–7.PubMedGoogle Scholar
  4. 4.
    Dixon AK, Kelsey-Fry I, Morson BC, Nicholls RJ, York-Mason A. Preoperative computed tomography of carcinoma of the rectum. Br J Radiol 1981;54:655–9.PubMedGoogle Scholar
  5. 5.
    Hall C, Silverman SH, Moore J, Thompson H, Keighley MRB. Intraoperative pelvic cytology accurately predicts those at risk of developing local recurrence of colorectal cancer (abstr). Br J Surg 1987;74:1149.Google Scholar
  6. 6.
    Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2:996–9.PubMedGoogle Scholar
  7. 7.
    Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1983;52:1317–29.PubMedGoogle Scholar
  8. 8.
    Martin DT, Hinkle GH, Tuttle S,et al. Intraoperative radioimmunodetection of colorectal tumour with hand-held radiation detector. Am J Surg 1985;50:672–5.Google Scholar
  9. 9.
    O'Dwyer PJ, Sickle-Santarello B, Mojzisik M, Thurston MD, Martin EW. Intraoperative radioimmunodetection of gastrointestinal neoplasms (abstr). Br J Surg 1987;74:1145.Google Scholar
  10. 10.
    Begent RHJ, Keep PA, Searle F,et al. Radioimmunolocalisation and selection for surgery in recurrent colorectal cancer. Br J Surg 1986;73:64–7.PubMedGoogle Scholar
  11. 11.
    Blair SD, Theodorou NA, Begent RH,et al. Comparison of anti-foetal microvillus and anti-CEA antibodies in peroperative radioimmunolocalisation of colorectal cancer. Br J Cancer 1989;61:891–4.Google Scholar
  12. 12.
    Harwood PJ, Britton DW, Southall PJ, Boxer GM, Rawlins G, Rogers GT. Mapping of epitope characteristics on carcinoembryonic antigen. Br J Cancer 1986;54:75–82.PubMedGoogle Scholar
  13. 13.
    Ledermann JA, Begent RH, Bagshawe KD,et al. Repeated antitumour antibody therapy in man with suppression of the host response with cyclosporin A. Br J Cancer 1987;58:654–7.Google Scholar
  14. 14.
    Begent RHJ, Ledermann JA, Green AJ,et al. Antibody distribution and dosimetry in patients receiving radiolabeled antibody for colorectal cancer. Br J Cancer 1989;60:406–12.PubMedGoogle Scholar
  15. 15.
    Aitkin DR, Thurston MD, Hinkle GH,et al. Portable gamma probe for radioimmuno-detection localization of experimental colon tumor xenografts. J Surg Res 1984;36:480–9.PubMedGoogle Scholar
  16. 16.
    Hamada Y, Yamamuka M, Hioki K, Yamaoto M, Nagura H, Watanabe K. Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer; correlation with plasma carcinoembryonic antigen levels. Cancer 1985;55:136–41.PubMedGoogle Scholar
  17. 17.
    Pedley RB, Boden JA, Boden RW, Green A, Boxer GM, Bagshawe KD. The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model. Br J Cancer 1989;60:549–54.PubMedGoogle Scholar
  18. 18.
    Herrerra-Ornelas L, Justiniano J, Castillo N,et al. Metastases in small lymph nodes from colon cancer. Arch Surg 1987;122:1253–6.PubMedGoogle Scholar
  19. 19.
    Enker WE, Heilwell ML, Herz RE,et al. En-bloc pelvic lymphadenectomy and sphincter preservation in the surgical management of rectal cancer. Ann Surg 1986;203:426–33.PubMedGoogle Scholar
  20. 20.
    McDonald JS. New approaches to management of colorectal carcinoma. Hosp Pract 1987;22:185–90.Google Scholar
  21. 21.
    Sardi A, Workman M, Mojzisik C,et al. Intra-abdominal recurrence of colorectal cancer detected by radioimmunoguided surgery (RIGS system). Arch Surg 1989;124:55–9.PubMedGoogle Scholar
  22. 22.
    Martin DT, Hinkle GH, Tuttle S,et al. Intraoperative radioimmunodetection of colorectal tumor with a hand-held radiation detector. Am J Surg 1985; 150:672–5.PubMedGoogle Scholar
  23. 23.
    Sickle-Santanello BJ, O'Dwyer PJ, Mojzisik C,et al. Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors. Dis Colon Rectum 1987;30:761–4.PubMedGoogle Scholar

Copyright information

© The American Society of Colon & Rectal Surgeons 1991

Authors and Affiliations

  • P. M. Dawson
    • 1
  • S. D. Blair
    • 1
  • R. H. J. Begent
    • 2
  • A. M. B. Kelly
    • 2
  • G. M. Boxer
    • 2
  • N. A. Theodorou
    • 1
  1. 1.Dept. of Gastrointestinal SurgeryCharing Cross HospitalLondonUK
  2. 2.Cancer Research Campaign LaboratoriesCharing Cross HospitalLondonUK

Personalised recommendations